FDA approves first subcutaneous C1 esterase inhibitor to treat rare genetic disease

5th July 2017 Uncategorised 0

American Pharmacists Association News

More: FDA approves first subcutaneous C1 esterase inhibitor to treat rare genetic disease
Source: MDlinx